Functional Foods as a New Therapeutic Strategy 2.0
A special issue of Nutraceuticals (ISSN 1661-3821).
Deadline for manuscript submissions: 31 December 2024 | Viewed by 23009
Special Issue Editors
Interests: functional foods; protein hydrolysate; antioxidant; immunomodulation; natural extracts; biopeptides; lupine; hemp; olive
Special Issues, Collections and Topics in MDPI journals
Interests: hydrolysates; peptides; lupine; oxidant stress; functional foods; nutraceuticals; atherosclerosis; MAFLD
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Functional foods have gained popularity in the scientific population due to their therapeutic and preventive use against certain pathological conditions.
Nowadays, numerous lines of research are dedicated to identifying bioactive compounds, as well as assessing their health properties. Thus, antioxidant, antihypertensive, anti-inflammatory, and antidiabetic effects, among others, have been demonstrated for a large number of bioactive ingredients. These investigations have been conducted in both in vitro and/or in vivo systems. The final aim of all these studies is to generate sufficient knowledge to prepare new functional foods that improve the human lifestyle, without using synthesized chemical compounds.
Thus, functional foods are the present and the future in the prevention of several diseases.
This new Special Issue is a continuation of the previous Special Issue, “Functional Foods as a New Therapeutic Strategy”, which was closed on 31 December 2022, including more than 10 valuable peer-reviewed papers.
It welcomes the submission of original articles or reviews that can improve knowledge about the beneficial effects of functional foods.
Dr. Ivan Cruz-Chamorro
Dr. Guillermo Santos Sánchez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutraceuticals is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.